Seroconversion after measles vaccination at nine and fifteen months of age

Isik N., Uzel N., Gokcay G., Kilic A., Yilmaz G., Sadikoglu B., ...Daha Fazla

PEDIATRIC INFECTIOUS DISEASE JOURNAL, cilt.22, sa.8, ss.691-695, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 8
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1097/01.inf.0000078158.23337.ed
  • Dergi Adı: PEDIATRIC INFECTIOUS DISEASE JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.691-695
  • Anahtar Kelimeler: measles, revaccination, immunogenicity, infant, children, RUBELLA MMR VACCINE, IMMUNE-RESPONSE, CHILDREN, INFANTS, IMMUNOGENICITY, IMMUNIZATION, ANTIBODY, REVACCINATION, FAILURE
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background. Despite high vaccination coverage, single dose measles immunization programs have been unsuccessful in eliminating the disease. Because seroconversion rates are lower in infants vaccinated before 12 months of age, a second dose of measles vaccine is recommended at 15 months. The aim of this study was to determine the seroconversion rates in children after the first and second doses of measles vaccinations at 9 and 15 months of age.